- This webinar has passed.
The ingredients for a successful life sciences investment
February 23, 2021 @ 12:30 pm - 1:30 pm
Join Guy Montague-Jones, React News analysis editor and a panel of industry experts as we investigate what ingredients make for a successful life sciences investment; exploring the different models, their strengths and weaknesses, and looking to the US where life science is more established at what lessons can be learnt, going into depth about the successes and pitfalls.
• What can we learn from the success of the life sciences market in the US?
• Where are the most promising locations for life sciences in the UK?
• How do you attract life sciences tenants? What are they looking for?
• What type of properties could be suitable for redevelopment to target life sciences? Business parks, retail?
• How important is specialist knowledge? How easily can non-specialists break into the market?
• What can go wrong and how do you avoid potential pitfalls?
Dentons Partner - Real Estate
Bonnie is a partner in the Real Estate practice group at Dentons. She focuses on high-end multidisciplinary transactions across the entire spectrum of real estate asset classes. She has a wealth of experience in acquisitions, sales, investment letting structures, real estate joint ventures and structuring with assets and portfolios in the UK, across Europe and on numerous cross-border transactions. Her clients include private equity and debt funds and she has represented some of the leading investment fund sponsors such as The Blackstone Group, Carval Investors and various sovereign wealth funds. She has a particular emphasis on inbound investment into the UK and Europe and has led transactions across all asset classes including offices, hotels, logistics, self-storage and student accommodation.
Co-founder of Harwell Oxford Partners, Harwell Campus Director
Angus provides thought leadership, real estate, marketing and networking support to organisations, people and places inside the UK Knowledge Economy. He is a firm believer in the power of research and innovation to deliver improved health, economic and social wellbeing. Having been a founding Private Sector Director and Shareholder at Harwell Campus (2013-2020), he continues to serve as Campus Director and sits on all Harwell’s Cluster Boards for Space, HealthTec and EnergyTec, plus the overarching Cluster Steering Group. Previously co-founded a consortium that secured a contract to acquire Pfizer’s 3 million square feet campus in Kent (2012). Other roles include: NED of Oxfordshire Local Enterprise Partnership & the Oxfordshire Growth Board.
CEO, Harrison Street Europe
Mr. Bashir joined the firm in 2020 and is a member of the firm’s European Investment Committee, Global Management Committee and serves on various boards for Harrison Street’s European Funds. As Chief Executive Officer of Europe, Mr. Bashir leads the expansion of Harrison Street’s European strategies and is responsible for overseeing and growing the firm’s team of professionals across the U.K. and Europe. Mr. Bashir brings over 20 years of experience in private equity real estate, operations and corporate finance to Harrison Street. Prior to joining Harrison Street, Mr. Bashir was most recently President and Chief Operating Officer at Round Hill Capital, a real estate investment and asset management firm with a global footprint. While at Round Hill Capital, he managed a business with a $8+ billion portfolio as well as a team of 260 people across 15 offices in 14 countries. He has overseen investment and development projects, regulatory approvals, complex refinancings and capital raises in multiple European locations across a wide array of real estate asset sectors including retail, commercial, residential and student housing. Prior to joining Round Hill, Mr. Bashir served as a Partner at Aggmore Group, where he was responsible for raising and deploying over €500 million of new capital and developed JV partnerships with European operators in the residential and commercial real estate space. Earlier he served as Chief Operating Officer at North Bridge Capital Partners Ltd. Mr. Bashir began his career at KPMG LLP as a senior manager in the transaction services department. Mr. Bashir earned a B.A. in Accounting and Financial Analysis from Newcastle University. Mr. Bashir is ACA qualified and is a member of The Institute of Chartered Accountants in England and Wales.
Investor and Developer Lead, Life Sciences, JLL
Chris is an experienced Director who leads the investor and developer service line for the UK Life Sciences group at JLL. Over the past 10 years Chris has provided independent, research led advice on mixed-use development schemes with a focus on science on behalf of landowners, developers and investors in London, the UK and internationally.
He has become a recognised expert on the life sciences market with a strong understanding of the sector, emerging trends and how this translates to new build development. His expertise comprises development consultancy, appraisal and transactional advice, with a clear focus on developing delivery and funding models for clients.